sellWeak cluster of 310b5-1 plan
Alexandra Balcom sold $1.7M of NUVL
Chief Financial Officer at Nuvalent, Inc.. 20,000 shares at an average of $84.67, traded Jul 15, 2025, filed Jul 17, 2025.
Warning score
37Value
$1.7M
20,000 shares
Holdings after
61,734
-30% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +25Trade size$1.7M at market
- +10Share of holdings soldSold 30% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-096637, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 15, 2025 | MOption exercise Class A Common Stock10b5-1 | +5,300 | $18.93 | $100k | 67,034 | Jul 17, 2025 |
| Jul 15, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -2,484 | $82.67 | $205k | 64,550 | Jul 17, 2025 |
| Jul 15, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,888 | $83.87 | $158k | 62,662 | Jul 17, 2025 |
| Jul 15, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -874 | $84.91 | $74k | 61,788 | Jul 17, 2025 |
| Jul 15, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -54 | $85.48 | $4,616 | 61,734 | Jul 17, 2025 |
| Jul 16, 2025 | MOption exercise Class A Common Stock10b5-1 | +14,700 | $18.93 | $278k | 76,434 | Jul 17, 2025 |
| Jul 16, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -14,700 | $85.10 | $1.3M | 61,734 | Jul 17, 2025 |
| Jul 15, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,300 | $0.00 | $0 | 81,700 | Jul 17, 2025 |
| Jul 16, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -14,700 | $0.00 | $0 | 67,000 | Jul 17, 2025 |
Related signals
Other insiders at Nuvalent, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 14Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $543k 5,500 shares | -8% | |
| 32Weak | Nuvalent, Inc. | Alexandra Balcom Chief Financial Officer | $2.5M 25,130 shares | -23% | |
| 30Weak | Nuvalent, Inc. | Henry E. Pelish Chief Scientific Officer | $3.4M 35,104 shares | -35% | |
| 30Weak | Nuvalent, Inc. | James Richard Porter President and CEO | $3.0M 30,000 shares | -8% | |
| 14Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $567k 5,500 shares | -8% | |
| 14Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $567k 5,500 shares | -9% | |
| 7Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $561k 5,500 shares | -9% | |
| 18Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $1.7M 15,000 shares | -25% | |
| 38Weak | Nuvalent, Inc. | Alexandra Balcom Chief Financial Officer | $721k 7,417 shares | -8% | |
| 35Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $676k 6,952 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.